Navigation Links
GlaxoSmithKline To Cultivate Non-Smoking Environment

GlaxoSmithKline is putting its best foot forward in completing its social responsibility. The steps will also enable the company promote Zyban, its anti-smoking drug. Glaxo is aiding companies cultivate a non-smoking environment as part of its policy, along with providing teams to help in the transition. //

Some of the corporate, which have negotiated for this 'no-smoking' environment, are Housing Development Finance Corporation, the Godrej group, Bharat Petroleum Corporation Ltd., Siemens, Tata Power and The Associated Cement Companies.

The Company is providing for on-line registration for Indian corporate interested in promoting no-smoking culture among its employees. In a step-by-step process, Glaxo is charting out a detailed programme for the employees. The team comprises a doctor and a counsellor. It also includes free education programmes and counselling sessions and Zyban at discounted prices.

Glaxo has also been conducting smoking cessation camps all over Mumbai. Glaxo has also set up a helpline in order to quit smoking. Glaxo had targeted 50,000 patients for its first year with Zyban. It has already crossed the target of 10,000 patients. It had also sponsored the academic grant for the global initiative for obstructive lung disease in order to promote educating the public for chronic obstructive pulmonary disease at the National Conference on pulmonary diseases.

Currently, the drug is priced at Rs. 40 for a 150-mg tablet. The dosage is once a day for the first three days and from the fourth day, two tablets for seven weeks.
'"/>




Page: 1

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
3. FDA Mislead On Asthma Drug By GlaxoSmithKline
4. GlaxoSmithKline Defends Its Products
5. GlaxoSmithKline launches diabetes and cancer drugs
6. Generic Products Compete With GlaxoSmithKline
7. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
8. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
9. GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD
10. GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find
11. GlaxoSmithKline Signs Outsourcing Deal With TCS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2017)... (PRWEB) , ... February 28, 2017 , ... Las Vegas ... revamped South Rancho location on Friday, March 10, 2017, 4-7 pm PST. For more ... but this clinic, located in the South Rancho neighborhood, has been renovated to provide ...
(Date:2/28/2017)... ... 28, 2017 , ... The role of females in the ... to civilian life. Body image dissatisfaction is largely unexamined among female veterans, a ... occurrence of chronic mental health conditions than female civilians. Female veterans also are ...
(Date:2/27/2017)... ... 27, 2017 , ... Hotze Health & Wellness Center (HHWC), ... its New Guest Director. , Brandl is a dynamic and influential executive ... began his professional career at Omnium Worldwide, now known as West Corporation, and ...
(Date:2/27/2017)... Nashville, TN (PRWEB) , ... February 27, 2017 , ... ... Dot Clayton went to work for a company involved in the underground testing of ... , In “Dying for Answers: Expendable Workers of the Cold War Nuclear Testing,” Clayton ...
(Date:2/27/2017)... ... February 26, 2017 , ... Miro is the ultimate ... and video system brings songs, movies, TV shows and much more apps for user ... high-definition sound. An immersive view of 1280 x 720 provides crisp images with remarkable ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... This report provides all the information you ... and activities since 2010. Download the full ... Deals and Alliance since 2010 report provides an in-depth ... world,s leading life sciences companies. On demand ... of the most up to date deal and company ...
(Date:2/28/2017)... -- Nordic Nanovector ASA (OSE: NANO) announces its results ... the results by the company,s senior management team will take place ... - details below. ... 2016 was a very successful year for Nordic Nanovector. We achieved ... with our preclinical candidates and build the foundation of R&D innovation ...
(Date:2/28/2017)... ... Research and Markets has announced the addition of the "Orthobiologics ... The global orthobiologics market is expected to reach USD 10.2 ... predominantly driven by the increasing orthopedic disease and musculoskeletal disease burden ... of orthobiologics are presumed to accelerate the market demand over the ...
Breaking Medicine Technology: